Thursday, February 9, 2012

New Data Suggest Oral Laquinimod May Confer Neuroprotection in Addition to Immunomodulation in the Treatment of …

New Data Suggest Oral Laquinimod May Confer Neuroprotection in Addition to Immunomodulation in the Treatment of …
LUND, SWEDEN–(Marketwire – 04/15/10) – – Enhanced levels of brain derived neurotrophic factor, possibly contributing to neuroprotection, were shown in laquinimod treated multiple sclerosis (MS) patients – Laquinimod significantly reduce demyelination and axonal damage as shown in animal models [...]

Powered by Yahoo! Answers